Robert Goeltz II Net Worth & Insider Trades

Robert Goeltz II - Chief Financial Officer, Arcus Biosciences, Inc

As of March 10, 2022

What is Robert Goeltz II's Net Worth?

The current estimated net worth of Arcus Biosciences, Inc's Chief Financial Officer, Robert Goeltz II, is estimated to be about $742.8K . Robert Goeltz II owns about 7,019 units of Arcus Biosciences, Inc common stock. In the last 2 years at Arcus Biosciences, Inc, Robert Goeltz II has sold an estimated value of $44.38K worth.

What is Robert Goeltz II's Past Insider Trading?

Robert Goeltz II's largest purchase order was 5,000 units , worth over $107.85K on September 9, 2020. Robert Goeltz II's largest sale order was 1,106 units , worth over $44.38K on December 20, 2021. In total, Robert Goeltz II has made about 5 transactions over 2 years of their time at Arcus Biosciences, Inc. Robert Goeltz II usually trades in March, January, December, August and September, with the busiest year in 2020 and 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Robert Goeltz II's' Mailing Address?

  • Mailing address is 343 Oyster Point Blvd Suite 100 South San Francisco CA 94080 CA

Arcus Biosciences, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Terry Rosen, Ph.D. 2020 $325,625 - $2,351,475 $2,351,475 - $1,200 $5,683,300
Terry Rosen, Ph.D. 2019 $340,000 - $1,375,700 $1,375,700 - $1,200 $1,716,900
Jennifer Jarrett 2020 $125,000 - $10,578,439 $10,578,439 $75,000 $28,171 $10,896,760
William Grossman, M.D., Ph.D. 2020 $457,600 - $2,073,420 $2,073,420 $250,000 $1,200 $6,134,970
William Grossman, M.D., Ph.D. 2019 $296,667 $200,000 $2,723,040 $2,723,040 $180,000 $600 $3,400,307
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1724521/000156459021019630/rcus-def14a_20210603.htm

What are Arcus Biosciences, Inc's Past Insider Trades?

Arcus Biosciences, Inc's most recent insider trade came on June 21, 2022 by Carolyn Tang Attorney-In-Fact who sold 2,922 units worth $62.67K . In the last 4 years, insiders at Arcus Biosciences, Inc have sold an estimated value of $6.32M and bought an estimated value of $227.36M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Terry Rosen, Chief Executive Officer,  Jennifer Jarrett, Chief Operating Officer,  and Juan Jaen, President .

Arcus Biosciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1